CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on understanding lethal prostate cancer by analyzing genomic data from patient samples. It aims to identify key genetic alterations and potential treatment strategies through innovative computational methods and in vitro validation.
Prostate cancer (PCA) is a genetically heterogeneous disease.
Advances in targeted hormonal therapy (second generation anti-androgens) have led to more effective management of castration-resistant prostate cancer (CRPC).
Despite these highly potent drugs, disease recurs with new genomic and epigenetic alterations.
In this ERC proposal, I will leverage my expertise in cancer genomics and a new computational methodology to unravel the landscape of lethal PCA, with a focus on determining the Achill…
UNIVERSITA DEGLI STUDI DI TRENTO
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
